Cargando…

The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer

Elucidating the mechanisms that underlie metastasis is of paramount importance to understanding tumor progression and to the development of novel therapeutics. Epithelial to Mesenchymal Transition (EMT) plays a vital role in tumor cell dissemination and is regulated by a core cassette of transcripti...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Anna, Wong, Christina S.F., Liu, Mira C.P., House, Colin M., Sceneay, Jaclyn, Bowtell, David D., Thompson, Erik W., Möller, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359261/
https://www.ncbi.nlm.nih.gov/pubmed/25528765
_version_ 1782361370245726208
author Chen, Anna
Wong, Christina S.F.
Liu, Mira C.P.
House, Colin M.
Sceneay, Jaclyn
Bowtell, David D.
Thompson, Erik W.
Möller, Andreas
author_facet Chen, Anna
Wong, Christina S.F.
Liu, Mira C.P.
House, Colin M.
Sceneay, Jaclyn
Bowtell, David D.
Thompson, Erik W.
Möller, Andreas
author_sort Chen, Anna
collection PubMed
description Elucidating the mechanisms that underlie metastasis is of paramount importance to understanding tumor progression and to the development of novel therapeutics. Epithelial to Mesenchymal Transition (EMT) plays a vital role in tumor cell dissemination and is regulated by a core cassette of transcription factors. Despite recent advances, the molecular pathways that regulate the EMT program have not yet been fully delineated. We show that Siah ubiquitin ligases regulate Zeb1 protein, a key EMT transcription factor. The induction of EMT in breast cancer cells leads to the down-regulation of Siah, while the loss of Siah induces a mesenchymal phenotype, concurrent with an up-regulation of Zeb1. Overexpression of Siah in vitro mediates Zeb1 degradation, which can be blocked with a Siah peptide inhibitor. Thus, this work demonstrates that Siah is a novel regulator of EMT. This work is the first to identify a mechanism of post-translational regulation of the key Epithelial to Mesenchymal Transition transcription factor Zeb1.
format Online
Article
Text
id pubmed-4359261
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-43592612015-03-27 The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer Chen, Anna Wong, Christina S.F. Liu, Mira C.P. House, Colin M. Sceneay, Jaclyn Bowtell, David D. Thompson, Erik W. Möller, Andreas Oncotarget Research Paper Elucidating the mechanisms that underlie metastasis is of paramount importance to understanding tumor progression and to the development of novel therapeutics. Epithelial to Mesenchymal Transition (EMT) plays a vital role in tumor cell dissemination and is regulated by a core cassette of transcription factors. Despite recent advances, the molecular pathways that regulate the EMT program have not yet been fully delineated. We show that Siah ubiquitin ligases regulate Zeb1 protein, a key EMT transcription factor. The induction of EMT in breast cancer cells leads to the down-regulation of Siah, while the loss of Siah induces a mesenchymal phenotype, concurrent with an up-regulation of Zeb1. Overexpression of Siah in vitro mediates Zeb1 degradation, which can be blocked with a Siah peptide inhibitor. Thus, this work demonstrates that Siah is a novel regulator of EMT. This work is the first to identify a mechanism of post-translational regulation of the key Epithelial to Mesenchymal Transition transcription factor Zeb1. Impact Journals LLC 2014-12-18 /pmc/articles/PMC4359261/ /pubmed/25528765 Text en Copyright: © 2015 Chen et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Chen, Anna
Wong, Christina S.F.
Liu, Mira C.P.
House, Colin M.
Sceneay, Jaclyn
Bowtell, David D.
Thompson, Erik W.
Möller, Andreas
The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
title The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
title_full The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
title_fullStr The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
title_full_unstemmed The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
title_short The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
title_sort ubiquitin ligase siah is a novel regulator of zeb1 in breast cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359261/
https://www.ncbi.nlm.nih.gov/pubmed/25528765
work_keys_str_mv AT chenanna theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT wongchristinasf theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT liumiracp theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT housecolinm theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT sceneayjaclyn theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT bowtelldavidd theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT thompsonerikw theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT mollerandreas theubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT chenanna ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT wongchristinasf ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT liumiracp ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT housecolinm ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT sceneayjaclyn ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT bowtelldavidd ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT thompsonerikw ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer
AT mollerandreas ubiquitinligasesiahisanovelregulatorofzeb1inbreastcancer